Results 321 to 330 of about 601,448 (407)

Hospitalizations for Severe Lower Respiratory Tract Infections

open access: yesPediatrics, 2014
A. Greenbaum   +7 more
semanticscholar   +1 more source

Median effective dosage of midazolam oral solution for preschool children in preoperative sedation

open access: yesIbrain, EarlyView.
This study aimed to detect median effective dosage (ED50) of midazolam oral solution (MOS) for preschool children in preoperative sedation. Thirty children who were scheduled for elective of the hidden penis correction surgery under general anesthesia in the pediatric surgery department were selected.
Rui Jiang   +5 more
wiley   +1 more source

Role of TREM1 in the sevoflurane‐induced inflammatory activation of microglia in vitro

open access: yesIbrain, EarlyView.
Perioperative neurocognitive disorders (PNDs) are one of the most common complications in perioperative patients, and neuroinflammatory reaction mediated by microglia plays a key role in their formation. Triggering receptor expressed on myeloid cells 1 (TREM1) is a key regulator of inflammation.
Chunchun Tang   +8 more
wiley   +1 more source

Sex differences in the impact of lower respiratory tract infections on older adults' health trajectories: a population-based cohort study. [PDF]

open access: yesBMC Infect Dis
Abbadi A   +7 more
europepmc   +1 more source

Engineered Living Energy Materials

open access: yesInterdisciplinary Materials, EarlyView.
Engineered living energy materials (ELEMs) are nascent research frontier for enabling sustainable energy conversion and storage. These materials exhibit unique characteristics such as self‐regeneration, biodegradability, environmental response, and evolutionary adaptability. This paper overviews different energy conversion bio‐modules, summarizes their
Xinyi Yuan   +14 more
wiley   +1 more source

Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial

open access: yesInternational Journal of Cancer, Volume 156, Issue 11, Page 2178-2187, 1 June 2025.
What's new? Bone metastases are common in a variety of cancer types, causing increased pain and worse outcomes. Suppression of bone turnover, such as with the monoclonal antibody denosumab, results in fewer skeletal complications and improved prognosis. Here, the authors demonstrate the safety and efficacy of a similar antibody, JMT103. Like denosumab,
Ran Ran   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy